Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chronic inflammatory activation in fat tissue and endothelial function in severe coronary artery disease
2007-001888-29Phase 4Terminated
- Sponsor
- Leipzig University
- Start
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of metformin and sitagliptin in coronary arteriosclerosis, prediabetes and impaired fasting glucose (IFG), sponsored by Leipzig University. Primary endpoint: Change in endothelial function. Started Oct 2007; status: terminated.
02
Drugs
metforminsitagliptin
03
Conditions
coronary arteriosclerosisprediabetesimpaired fasting glucose (IFG)
Beyond the preview
Go deeper on 2007-001888-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001888-29.